MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Personalis Depreciation & Amortization 2011-2026 | PSNL
Annual Depreciation & Amortization Personalis
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.9 M | 11.3 M | 8.43 M | 6.01 M | 5.76 M | 4.75 M | 3.07 M | 1.22 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 11.3 M | 1.22 M | 6.43 M |
Quarterly Depreciation & Amortization Personalis
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.4 M | 2.5 M | 2.59 M | - | 2.76 M | 2.8 M | 2.84 M | - | 2.8 M | 2.8 M | 2.78 M | - | 1.9 M | 1.8 M | 1.77 M | - | 1.5 M | 1.4 M | 1.52 M | - | 1.5 M | 1.4 M | 1.4 M | - | 1.2 M | 1.1 M | 1.05 M | - | 900 K | 700 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.84 M | 700 K | 1.89 M |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
BioNano Genomics
BNGO
|
14 M | $ 1.12 | -0.88 % | $ 1.42 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
47.8 M | $ 28.4 | -1.41 % | $ 306 M |  China |
 |
Aspira Women's Health
AWH
|
264 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
1.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Celcuity
CELC
|
130 K | $ 106.01 | 0.82 % | $ 4.18 B | USA |
 |
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | USA |
 |
Check-Cap Ltd.
CHEK
|
161 K | - | - | $ 9.42 M |  Israel |
 |
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | USA |
 |
DarioHealth Corp.
DRIO
|
473 K | $ 11.26 | - | $ 319 M | Israel |
 |
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
1.23 M | - | - | $ 79.8 M | USA |
 |
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M | China |
 |
Fulgent Genetics
FLGT
|
24.9 M | $ 23.02 | 0.04 % | $ 696 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
493 M | $ 209.34 | 0.95 % | $ 23.2 B | USA |
 |
Castle Biosciences
CSTL
|
16 M | $ 30.02 | 3.73 % | $ 834 M | USA |
 |
CareDx, Inc
CDNA
|
14.4 M | $ 19.18 | 2.08 % | $ 1.03 B | USA |
 |
Danaher Corporation
DHR
|
750 M | $ 209.79 | -0.58 % | $ 153 B | USA |
 |
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | USA |
 |
DexCom
DXCM
|
252 M | $ 72.99 | -0.38 % | $ 28.5 B | USA |
 |
Interpace Biosciences
IDXG
|
300 K | $ 1.74 | -5.95 % | $ 7.63 M | USA |
 |
Exact Sciences Corporation
EXAS
|
125 M | $ 103.46 | 0.07 % | $ 19.5 B | USA |
 |
Guardant Health
GH
|
39.7 M | $ 96.45 | 2.15 % | $ 12.1 B | USA |
 |
QIAGEN N.V.
QGEN
|
203 M | - | - | $ 10.6 B |  Niderland |
 |
Laboratory Corporation of America Holdings
LH
|
681 M | $ 287.1 | 0.62 % | $ 24.1 B | USA |
 |
Charles River Laboratories International
CRL
|
403 M | $ 166.77 | 1.98 % | $ 8.27 B | USA |
 |
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | USA |
 |
ICON Public Limited Company
ICLR
|
488 M | $ 104.81 | 0.14 % | $ 8.65 B |  Irlanda |
 |
ENDRA Life Sciences
NDRA
|
46.5 K | $ 3.77 | 0.53 % | $ 2.02 M | USA |
 |
IDEXX Laboratories
IDXX
|
145 M | $ 648.66 | 4.1 % | $ 52.2 B | USA |
 |
Illumina
ILMN
|
354 M | $ 123.46 | 2.42 % | $ 19.6 B | USA |
 |
IQVIA Holdings
IQV
|
1.14 B | $ 164.94 | 1.75 % | $ 28.4 B | USA |
 |
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
51.1 M | $ 1 382.99 | -0.81 % | $ 28.5 B |  Schweiz |
|
Biodesix
BDSX
|
5.77 M | $ 13.28 | 3.99 % | $ 1.72 B | USA |
 |
Natera
NTRA
|
16.7 M | $ 209.72 | 0.18 % | $ 20.6 B | USA |
 |
Lantheus Holdings
LNTH
|
64.6 M | $ 73.43 | 0.01 % | $ 5.08 B | USA |
 |
Biomerica
BMRA
|
87 K | $ 2.11 | 0.49 % | $ 4.85 M | USA |
 |
Bioventus
BVS
|
57.4 M | $ 8.71 | 0.58 % | $ 546 M | USA |
 |
Medpace Holdings
MEDP
|
27.2 M | $ 442.92 | -0.46 % | $ 12.8 B | USA |